跳至主要内容
临床试验/NCT06573086
NCT06573086招募中不适用

Towards Personalized Exercise: Identifying the Determinants of Individual Variation in Repeated Resistance Training (TraDeRe) and Examining Transferability of Responsiveness Between Resistance Training and Endurance Training

University of Jyvaskyla1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年8月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Change in m. vastus lateralis (VL) cross-sectional area (CSA) with ultrasound (US)

研究概览

简要总结

The goals of our research project are to identify factors explaining inter-individual variation in responses to resistance training (RT) and the baseline determinants underlying an individual's sensitivity to respond to RT. Moreover, investigators aim to assess whether a responsiveness to RT predicts responsiveness to endurance training (ET). Thus, investigators aim to gain a deeper understanding of exercise adaptation processes. The main questions investigators aim to answer are:

  • Can the physiological responses of one RT intervention be extrapolated to a subsequent RT intervention?
  • If so, what are the mechanisms underlying differing skeletal muscle growth responses in low, and high responders of skeletal muscle hypertrophy?
  • If so, do the low responders of skeletal muscle growth respond more favourably when the amount of RT is increased?
  • Are the high, moderate, and low responders of RT also the highest, moderate, and lowest responders to ET?

To examine these main research questions, high (n=30), low (n=30), and moderate (n=30) responders of skeletal muscle growth in response to RT (intervention I, NCT05874986) are reallocated into a subsequent 12-week RT intervention (intervention II) after a detraining period. A subgroup of these participants (n=10) will engage in a 6-week control period before starting the second RT period. Additionally, after intervention II, participants will participate in an ET intervention, lasting 6 weeks.

In this intervention II, reallocated participants will be:

  • Resistance training with supervision for 12 weeks
  • Consuming deuterium oxide for the assessment of muscle protein synthesis
  • Consuming D3-3-methylhistidine for the assessment of acute muscle protein breakdown
  • Consuming D3-creatine for the examination of whole-body skeletal muscle mass
  • Providing a spot urine sample six (6) times, and urine collection for 24 hours performed twice
  • Providing saliva samples (30-32 in total) for the assessment of body water enrichment of deuterium
  • Providing a muscle biopsy four or five (4-5) times during the study
  • Providing a blood sample fourteen (14) times during the study
  • Assessed for body composition and body volume four or five times (4-5) during the study
  • Participating in muscle size, maximal dynamic strength and TMS measurements four or five (4-5) times during the study
  • Asked to answer questionnaires related to e.g. stress, physical activity, sleep, perceived exertion, and diet
  • Participating in recovery measurements before and after the second-to-last and the last RT bout, and once in the days between these RT bouts, consisting of six (6) body volume measurements and six (6) maximal voluntary isometric contraction (kg) tests using horizontal leg press for the assessment of neuromuscular recovery
  • Participating in an acute resistance exercise (RE) after the 12-week RT intervention.

Furthermore, in the ET intervention, participants will be:

  • Participating in a familiarization session and resting electrocardiograph measurements before the intervention
  • Participating in endurance testing consisting of body composition, movement economy, and incremental RAMP testing before and after ET intervention
  • Endurance training with supervision for 6 weeks, three times a week.

详细描述

While the diverse health and performance benefits of resistance training (RT) are widely recognized, some individuals demonstrate notably divergent responses to RT intervention. This phenomenon is termed inter-individual response variation to RT. However, despite the prevalence of these research findings, the precise underlying mechanisms contributing to these differential RT responses remain ambiguous. Finally, it is currently unknown whether a responsiveness to RT predicts responsiveness to ET within the same set of participants, as this area of research is critically understudied.

Investigators aim to investigate the cellular, molecular, and neuromuscular mechanisms behind the plausible RT response variability intra- and inter-individually, using trial-to-trial, i.e. resistance training, detraining, and retraining design. Moreover, as the impact of diverse polygenic effects on RT responsiveness is yet to be determined, investigators will employ a multi-OMIC (genomic, epigenomic, transcriptomic, proteomic, and metabolomic) approach to unravel previously unknown denominators of RT responsiveness. Finally, numerous environmental factors, e.g. nutrition, stress, sleep, and physical activity are monitored during the study to assess the effects of non-physiological mechanisms on RT response variability.

In our study, 362 healthy male and female participants in total started in the study and were destined to undergo an RT period of 12 weeks in two separate periods (intervention I refers to NCT05874986). Then, a subset of the participants from intervention I will be reallocated into intervention II based on the magnitude increase of m. vastus lateralis (VL) cross-sectional area (CSA) assessed by ultrasound using extended-field-of-view mode. Similar to intervention I, intervention II will be performed in separate periods similarly to the data collection I and II of intervention I to first accumulate approximately 32 weeks of detraining for both cohorts, after which 12 weeks of RT is performed.

Moreover, a subset (n=30) of the participants aged 40-50 from intervention I not selected for intervention II have a chance to take part in a 10-week home training sub-study. These participants will be randomized to a non-training control group (n=15) and a home training group (n=15). The home training group will carry out a 10-week RT period utilizing muscle-strengthening activities in their home. This sub-study investigates how minimally supervised RT executed at home after supervised gym RT can maintain muscle strength and size compared to non-training. Home training is flexible, time-saving, and inexpensive. It is also done twice weekly using safe and effective training protocols and movements. Home-based training includes pistol squat, reverse nordic, push up, and bent-over row, and bicep curl exercises. To achieve progression, the total load will be increased by increasing the number of repetitions per set, and/or increasing the load by using a progression from easier to more difficult techniques and/or by adding resistance bands, which will be provided to participant's free of charge for the duration of the study. Participants will be contacted regularly to ensure motivation and adherence to home exercise. All the participants in this sub-study, as well as the other participants not selected for intervention II are offered a self-directed, non-supervised 7-week RT period with a similar design as in intervention I with access to our gym located in our Faculty's building. VL CSA, horizontal leg press 1 repetition maximum, and body composition will be assessed before and after home training and self-directed RT for each participant.

In intervention II, participants will be performing RT similarly to intervention I. However, for the last 5 weeks of the intervention, RT volume will be increased by 40 % for the lower body exercises to assess the impact of RT volume increment on RT responses. After 12 weeks of RT, an experimental RT session will be conducted to assess the acute physiological responses to resistance exercise. The experimental session will consist of five heavy sets of both horizontal leg press and leg extension exercises. During the last RT week, participants will engage in recovery measurements before and after the second-to-last and the last RT bout, and once during the days between these two bouts. After 12 weeks of RT, participants will be performing an additional acute resistance exercise session. All the participants NOT selected for intervention II are able to participate in a self-directed, 6-week RT period with measurements before and after this period. These measurements include body composition, muscle size (VL CSA and muscle thickness of elbow flexors) and muscle strength (dynamic 1RM of horizontal leg press and barbell scott curl) assessments. A subgroup of the participants (n=10) will engage in a control period of 6 weeks in duration, before the onset of RT.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •age 18-50
  • •healthy (e.g., no diagnosed type 2 diabetes, cardiovascular disease, musculoskeletal disorders, etc.)
  • •prior participation in intervention I (NCT05874986)

排除标准

  • •medication affecting the cardiovascular system or metabolism
  • •metabolic, musculoskeletal, cardiovascular, or other diseases or disorders which may preclude the ability to perform exercise training and testing

研究组 & 干预措施

Moderate responders (n=30)

Experimental

This group consists of participants with the moderate increase in skeletal muscle hypertrophy of m. vastus lateralis in response to the initial 12 weeks of RT (Intervention I).

干预措施: Resistance Training (Other)

High responders (n=30)

Experimental

This group consists of participants with the highest increase in skeletal muscle hypertrophy of m. vastus lateralis in response to the initial 12 weeks of RT (Intervention I).

干预措施: Resistance Training (Other)

Low Responders (n=30)

Experimental

This group consists of participants with the lowest increase in skeletal muscle hypertrophy of m. vastus lateralis in response to the initial 12 weeks of RT (Intervention I).

干预措施: Resistance Training (Other)

结局指标

主要结局

Change in m. vastus lateralis (VL) cross-sectional area (CSA) with ultrasound (US)

时间窗: Baseline (test and retest), week 7, week 13

VL CSA (cm\^2) is determined at mid-thigh using a B-mode axial plane US (Venue Fit R4, GE Medical Systems, USA) with a L4-20t-RS linear-array probe (48,43 mm width) in extended-field-of-view mode (6/12 MHz, 39 frames per second). Additionally, VL CSA (cm\^2) will also be determined at baseline with different US, at mid-thigh using a B-mode axial plane US (model SSD-α10, Aloka, Tokyo, Japan) with a 13 MHz linear-array probe (60 mm width) in extended-field-of-view mode (23 Hz sampling frequency). Aloka-US was used in the intervention I, but GE-US in intervention II due to the progressive malfunctioning of Aloka. Therefore, both machines are used in baseline measurements to calculate the plausible inter-US variability. The CSA will be measured using the polygon function in ImageJ software. Per each measurement, three images will be analysed from which the average from the two closest ones will be calculated.

次要结局

  • Change in muscle fiber capillarization(Baseline, week 7, week 13)
  • Change in myonuclear content of the muscle fibers(Baseline, week 13)
  • Change in satellite cell content during the intervention of the muscle fibers(Baseline, week 13)
  • Change in muscle fiber cross-sectional area (CSA) during the intervention period(Baseline, week 7, week 13)
  • Change in macrophage content of the muscle fibers(Baseline, week 7, week 13)
  • Changes in anaerobic enzymes(Baseline, week 7, week 13)
  • Changes in sarcoplasmic protein contents(Baseline, week 7, week 13)
  • Change in whole body fat-free mass(Baseline (test and retest), week 7, week 13)
  • Change in whole-body volume (cm^3)(Baseline (test and retest), week 7, week 13, before and after 6-weeks of ET.)
  • Change in blood count determined from the venous blood sample obtained in the morning after overnight fasting before, mid, and after 12-week resistance training(Baseline (test and retest), week 7, week 13)
  • Change in C-reactive protein (CRP) determined from the venous blood sample obtained in the morning after overnight fasting before, mid, and after 12-week resistance training(Baseline, week 7, week 13)
  • Satellite cell isolation(Week 13)
  • Change in whole body fat mass(Baseline (test and retest), week 7, week 13)
  • Self-report of eating disorder behaviors and attitudes(Baseline, week 13)
  • Self-estimated energy availability(Week 13)
  • Self-measure of perceived stress(Baseline, week 7, week 13)
  • Recovery of muscle swelling after acute resistance exercise (RE)(Week 12: before and after the second last and the last training session, and once during the days in between)
  • Changes in blood lactate concentration(Baseline, week 1 of ET, week 7 (post))
  • Changes in blood glucose concentration(Baseline, week 1 of ET, week 7 (post))
  • Changes in hematocrit(Baseline, week 7 (post))
  • Changes in hemoglobin concentration(Baseline, week 7 (post))
  • Changes in respitatory exhange ratio (RER)(Baseline, week 7 (post))
  • Changes in arterial oxygen saturation(Baseline, week 7 (post))
  • Changes in subjective rating of perceived exertion (RPE)(Baseline, weeks 1-6 of ET, week 7 (post))
  • Aerobic threshold(Familiarization)
  • Sleep self-assessment(Baseline, week 13)
  • Changes in movement economy(Baseline, week 7 (post))
  • Blood pressure(Baseline, week 7 (post))
  • Changes in heart rate variability (HRV)(Baseline, week 7 (post))
  • Change in ribosome biogenesis(Baseline, week 7, week 13)
  • Muscle protein synthesis (MPS) with the Combined Oral Stable Isotope Assessment of Muscle (COSIAM)(From baseline to week 7 (6 weeks of RT in duration))
  • Muscle protein breakdown (MPB) with the Combined Oral Stable Isotope Assessment of Muscle (COSIAM)(Baseline, Week 7)
  • Change in whole-body skeletal muscle mass (SMM) with the Combined Oral Stable Isotope Assessment of Muscle (COSIAM)(Baseline, Week 7)
  • Change in muscle thickness (MT) of the elbow flexors after 6 and 12-week resistance training(Baseline (test and retest), week 7, week 13)
  • Change in lower and upper limb maximal strength after 6 and 12-week resistance training(Baseline (test and retest), week 7, week 13,)
  • Change in corticoreticular excitability after resistance training with transcranial magnetic stimulation (TMS)(Baseline (test and retest), week 7, week 13)
  • Changes in multiomics during the intervention(Baseline, week 13)
  • Self-reported measure of physical activity(Baseline, week 13)
  • Recovery of muscle strength after acute resistance exercise (RE)(Week 12: before and after the second last and the last training session, and once during the days in between)
  • Subjective muscle soreness after acute resistance exercise (RE)(Week 12: before the second last and the last training session, and once during the days in between)
  • Time to exhaustion (TTE)(Baseline, week 7 (post))
  • Change in maximal oxygen uptake(Baseline, week 7 (post))
  • Change in the first ventilatory threshold(Baseline, week 7 (post))
  • Change in the second ventilatory threshold(Baseline, week 7 (post))
  • Changes in cardiac output(Baseline, week 7 (post))
  • Changes in stroke volume(Baseline, week 7 (post))
  • Changes in heart rate(Baseline, weeks 1-6 of ET, week 7 (post))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Juha Ahtiainen

Associate Professor

University of Jyvaskyla

研究点 (1)

Loading locations...

相似试验